{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T03:17:06Z","timestamp":1760239026645,"version":"build-2065373602"},"reference-count":27,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T00:00:00Z","timestamp":1599782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"JSPS KAKENHI Grant Number","award":["19K07453"],"award-info":[{"award-number":["19K07453"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Cancers of the breast and endometrium are some of the most common cancers affecting women [...]<\/jats:p>","DOI":"10.3390\/cancers12092595","type":"journal-article","created":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T09:05:16Z","timestamp":1599815116000},"page":"2595","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["New Insights into Breast and Endometrial Cancers"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3618-5652","authenticated-orcid":false,"given":"Yasuhiro","family":"Miki","sequence":"first","affiliation":[{"name":"Department of Disaster Obstetrics and Gynecology, International Research Institute of Disaster Science (IRIDeS), Tohoku University, Sendai 980-0000, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,9,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Ignatov, A., and Ortmann, O. (2020). Endocrine Risk Factors of Endometrial Cancer: Polycystic Ovary Syndrome, Oral Contraceptives, Infertility, Tamoxifen. Cancers, 12.","DOI":"10.3390\/cancers12071766"},{"key":"ref_2","unstructured":"(2020, September 11). Endometrial Cancer: A guide for patients\u2014Information based on ESMO Clinical Practice Guidelines\u2014v.2012.1. Available online: https:\/\/www.esmo.org\/content\/download\/6604\/115031\/file\/EN-Endometrial-Cancer-Guide-for-Patients.pdf."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Levine","year":"2013","journal-title":"Nature"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"D\u00f6rk, T., Hillemanns, P., Tempfer, C., Breu, J., and Fleisch, M.C. (2020). Genetic Susceptibility to Endometrial Cancer: Risk Factors and Clinical Management. Cancers, 12.","DOI":"10.3390\/cancers12092407"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Vydra, N., Janus, P., Toma-Jonik, A., Stokowy, T., Mrowiec, K., Korfanty, J., D\u0142ugajczyk, A., Wojtas, B., Gielniewski, B., and Wid\u0142ak, W. (2019). 17\u03b2-Estradiol Activates HSF1 via MAPK Signaling in ER\u03b1-Positive Breast Cancer Cells. Cancers, 11.","DOI":"10.3390\/cancers11101533"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Cotul, E.K., Smith, B.P., Wrobel, K., Zhao, Y.C., Chen, K.L.A., Hieronymi, K., Imir, O.B., Duong, K., O\u2019Callaghan, C., and Mehta, A. (2019). Combined Targeting of Estrogen Receptor Alpha and XPO1 Prevent Akt Activation, Remodel Metabolic Pathways and Induce Autophagy to Overcome Tamoxifen Resistance. Cancers, 11.","DOI":"10.3390\/cancers11040479"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Lypova, N., Lanceta, L., Gipson, A., Vega, S., Garza-Morales, R., McMasters, K.M., Chesney, J., Gomez-Gutierrez, J., Imbert-Fernandez, Y., and Gibson, A. (2019). Targeting Palbociclib-Resistant Estrogen Receptor-Positive Breast Cancer Cells via Oncolytic Virotherapy. Cancers, 11.","DOI":"10.3390\/cancers11050684"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Pop\u0119da, M., Stokowy, T., Bednarz-Knoll, N., Jurek, A., Niemira, M., Bielska, A., Kr\u0119towski, A., Kalinowski, L., Szade, J., and Markiewicz, A. (2019). NF-kappa B Signaling-Related Signatures Are Connected with the Mesenchymal Phenotype of Circulating Tumor Cells in Non-Metastatic Breast Cancer. Cancers, 11.","DOI":"10.3390\/cancers11121961"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Catalano, S., Panza, S., Augimeri, G., Giordano, C., Malivindi, R., Gelsomino, L., Marsico, S., Giordano, F., Gy\u0151rffy, B., and Bonofiglio, D. (2019). Phosphodiesterase 5 (PDE5) Is Highly Expressed in Cancer-Associated Fibroblasts and Enhances Breast Tumor Progression. Cancers, 11.","DOI":"10.3390\/cancers11111740"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Bandini, E., Rossi, T., Gallerani, G., and Fabbri, F. (2019). Adipocytes and microRNAs Crosstalk: A Key Tile in the Mosaic of Breast Cancer Microenvironment. Cancers, 11.","DOI":"10.3390\/cancers11101451"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Rosa-Rosa, J.M., Caniego-Casas, T., Leskela, S., Cristobal, E., Gonz\u00e1lez-Mart\u00ednez, S., Moreno, E., L\u00f3pez-Miranda, E., Holgado, E., P\u00e9rez-Mies, B., and Garrido, P. (2019). High Frequency of ERBB2 Activating Mutations in Invasive Lobular Breast Carcinoma with Pleomorphic Features. Cancers, 11.","DOI":"10.3390\/cancers11010074"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Quiroz, J., Garc\u00eda-Becerra, R., Cuevas, C.L.S., Ram\u00edrez-Nava, G., Morales-Guadarrama, G., C\u00e1rdenas-Ochoa, N., Segovia-Mendoza, M., Prado-Garc\u00eda, H., Ordaz-Rosado, D., and Avila, E. (2019). Synergistic Antitumorigenic Activity of Calcitriol with Curcumin or Resveratrol is Mediated by Angiogenesis Inhibition in Triple Negative Breast Cancer Xenografts. Cancers, 11.","DOI":"10.3390\/cancers11111739"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Wang, Y., Qi, Y.-X., Qi, Z., and Tsang, S.-Y. (2019). TRPC3 Regulates the Proliferation and Apoptosis Resistance of Triple Negative Breast Cancer Cells through the TRPC3\/RASA4\/MAPK Pathway. Cancers, 11.","DOI":"10.3390\/cancers11040558"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Mangia, A., Saponaro, C., Vagheggini, A., Opinto, G., Centonze, M., Vicenti, C., Popescu, O., Pastena, M., Giotta, F., and Silvestris, N. (2019). Should Tumor Infiltrating Lymphocytes, Androgen Receptor, and FOXA1 Expression Predict the Clinical Outcome in Triple Negative Breast Cancer Patients?. Cancers, 11.","DOI":"10.20944\/preprints201908.0109.v1"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"De Nonneville, A., Finetti, P., Adelaide, J., Lambaudie, E., Viens, P., Gon\u00e7alves, A., Birnbaum, D., Mamessier, E., and Bertucci, F. (2019). A Tyrosine Kinase Expression Signature Predicts the Post-Operative Clinical Outcome in Triple Negative Breast Cancers. Cancers, 11.","DOI":"10.3390\/cancers11081158"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Behrouzi, R., Ryan, N.A.J., Barr, C.E., Derbyshire, A.E., Wan, Y.L., Maskell, Z., Stocking, K., Pemberton, P.W., Bolton, J., and McVey, R.J. (2020). Baseline Serum HE4 But Not Tissue HE4 Expression Predicts Response to the Levonorgestrel-Releasing Intrauterine System in Atypical Hyperplasia and Early Stage Endometrial Cancer. Cancers, 12.","DOI":"10.3390\/cancers12020276"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Takeuchi, M., Tanikawa, M., Nagasaka, K., Oda, K., Kawata, Y., Oki, S., Agapiti, C., Sone, K., Miyagawa, Y., and Hiraike, H. (2019). Anti-Tumor Effect of Inhibition of DNA Damage Response Proteins, ATM and ATR, in Endometrial Cancer Cells. Cancers, 11.","DOI":"10.3390\/cancers11121913"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Roman-Canal, B., Moiola, C.P., Gatius, S., Bonnin, S., Ruiz-Mir\u00f3, M., Gonz\u00e1lez, E., Gonz\u00e1lez-Tallada, X., Llordella, I., Hern\u00e1ndez, I., and Porcel, J.M. (2019). EV-Associated miRNAs from Peritoneal Lavage are a Source of Biomarkers in Endometrial Cancer. Cancers, 11.","DOI":"10.3390\/cancers11060839"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Delangle, R., De Foucher, T., Larsen, A.K., Sabbah, M., Aza\u00efs, H., Bendifallah, S., Dara\u00ef, E., Ballester, M., M\u00e9hats, C., and Uzan, C. (2019). The Use of microRNAs in the Management of Endometrial Cancer: A Meta-Analysis. Cancers, 11.","DOI":"10.3390\/cancers11060832"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Dong, P., Xiong, Y., Yue, J., Hanley, S.J.B., Kobayashi, N., Todo, Y., and Watari, H. (2019). Exploring lncRNA-Mediated Regulatory Networks in Endometrial Cancer Cells and the Tumor Microenvironment: Advances and Challenges. Cancers, 11.","DOI":"10.3390\/cancers11020234"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"O\u2019Mara, T.A., Spurdle, A.B., and Glubb, D. (2019). Endometrial Cancer Association Consortium Endometrial Cancer Association Consortium; Endometrial Cancer Association Consortium Analysis of Promoter-Associated Chromatin Interactions Reveals Biologically Relevant Candidate Target Genes at Endometrial Cancer Risk Loci. Cancers, 11.","DOI":"10.1101\/751081"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Njoku, K., Chiasserini, D., Whetton, A.D., and Crosbie, E.J. (2019). Proteomic Biomarkers for the Detection of Endometrial Cancer. Cancers, 11.","DOI":"10.3390\/cancers11101572"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Espedal, H., Fonnes, T., Fasmer, K.E., Krakstad, C., and Haldorsen, I.S. (2019). Imaging of Preclinical Endometrial Cancer Models for Monitoring Tumor Progression and Response to Targeted Therapy. Cancers, 11.","DOI":"10.3390\/cancers11121885"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jsbmb.2011.12.004","article-title":"The advantages of co-culture over mono cell culture in simulating in vivo environment","volume":"131","author":"Miki","year":"2012","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"R323","DOI":"10.1530\/ERC-15-0470","article-title":"In situ androgen and estrogen biosynthesis in endometrial cancer: focus on androgen actions and intratumoral production","volume":"23","author":"Ito","year":"2016","journal-title":"Endocr.-Relat. Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s10549-017-4464-5","article-title":"Effects of cytokines derived from cancer-associated fibroblasts on androgen synthetic enzymes in estrogen receptor-negative breast carcinoma","volume":"166","author":"Kikuchi","year":"2017","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Hashimoto, C., Miki, Y., Tanaka, S., Takagi, K., Fue, M., Doe, Z., Li, B., Yaegashi, N., Suzuki, T., and Ito, K. (2018). 17\u03b2-Hydroxysteroid Dehydrogenase Type 2 Expression Is Induced by Androgen Signaling in Endometrial Cancer. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19041139"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/12\/9\/2595\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:09:04Z","timestamp":1760177344000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/12\/9\/2595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,11]]},"references-count":27,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,9]]}},"alternative-id":["cancers12092595"],"URL":"https:\/\/doi.org\/10.3390\/cancers12092595","relation":{},"ISSN":["2072-6694"],"issn-type":[{"type":"electronic","value":"2072-6694"}],"subject":[],"published":{"date-parts":[[2020,9,11]]}}}